NCT03604471View on ClinicalTrials.gov

Lipid-lowering Therapy Individualization

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

August 8, 2017

Primary Completion Date

August 27, 2019

Study Completion Date

August 27, 2019

Conditions
Hypercholesterolemia
Interventions
DRUG

Atorvastatin

Blood sampling for atorvastatin quantification and pharmacogenetic analysis.

Trial Locations (1)

1200

Cliniques universitaires Saint-Luc, Brussels

All Listed Sponsors
collaborator

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

lead

Université Catholique de Louvain

OTHER

NCT03604471 - Lipid-lowering Therapy Individualization | Biotech Hunter | Biotech Hunter